UK stocks were putting in solid gains on Wednesday morning after a sharper-than-expected fall in consumer price inflation all but cemented a rate cut at the Bank of England's next meeting.

GSK announced on Wednesday that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for gepotidacin, a first-in-class oral antibiotic, under priority review.

European shares were lower at the open on Wednesday after a mixed session on Asian markets and declines on Wall Street, while investors also digested the latest UK inflation data showing a fall below ...

London open The FTSE 100 is expected to open 17 points higher on Wednesday, having closed down 0.52% on Tuesday at 8,249.28.

Stock futures were pointing to a slightly higher start for London's top-flight index on Wednesday following the release of a weaker-than-expected reading on UK inflation.

Premier Inn owner Whitbread on Wednesday lifted its half-year dividend and said it would buy back an additional £100m in ...

UK inflation dropped sharply in September to its lowest level in two and a half years, according to data from the Office for National Statistics on Wednesday, likely ramping up the pressure on the ...

The future ownership of the water industry should be decided by a citizens’ assembly to remove decision-making from ...

Financial markets' focus in the middle of the week will be on the latest UK inflation data. At 0700 BST the Office for National Statistics is expected to report that the annual rate of increase in ...

Wall Street stocks were in the red at the close of trading on Tuesday as Q3 earnings season kicked up a gear. At the close, ...

London markets ended Tuesday in negative territory, driven primarily by a sharp decline in energy stocks following a drop in ...

Kettle safety and water technology specialist Strix Group announced a significant milestone on Tuesday, having produced over ...